September 28, 2026Biossil raises $153-million in OpenAI-led funding to bring resuscitated drugs to market4 min read
September 21, 2026U.S. government can take share of Canadian drug sales under pricing deals, documents suggest3 min read
September 18, 2026Xenon stock plunges as B.C. drug developer pauses enrolment in depression study3 min read
September 17, 2026Second Alzheimer’s-treating drug should be publicly covered, Canada’s Drug Agency recommends3 min read
September 16, 2026Sanofi inaugurates Toronto facility that will produce seasonal flu vaccines for Canadians2 min read
August 21, 2026explainerWhat to know about Grifols plasma collection centres and Health Canada’s safety concerns6 min read
August 19, 2026analysisModerna, Merck’s cancer vaccine breakthrough could open new avenue of treatment3 min read
August 17, 2026Health Canada approves drug to treat hot flashes and night sweats in breast cancer patients4 min read
August 16, 2026opinionOttawa is ignoring the beating heart of the life sciences sectorE. Richard Gold4 min read
August 12, 2026Apotex reports $38-million net loss in first quarter after going public in June1 min read
August 11, 2026AbCellera launches $200-million equity offering on heels of strong menopause trial results3 min read
August 10, 2026AbCellera stock soars on ‘off the chart’ trial results from hot flash treatment for menopausal women4 min read
August 4, 2026Apotex a ‘standout’ stock since IPO despite Trump tariff threat, analysts say4 min read
August 3, 2026AstraZeneca investors punish firm over reports of $400-billion Bristol Myers pharma deal3 min read
July 30, 2026Kneat investors vote for Thoma Bravo buyout as exodus of TSX-listed software names continues3 min read
March 9, 2026Xenon stock soars as B.C. drug developer reports strong results for epilepsy treatment3 min read
